Peptide-directed highly selective targeting of pulmonary arterial hypertension.
about
Decorin: A Growth Factor Antagonist for Tumor Growth InhibitionSystemically Administered, Target Organ-Specific Therapies for Regenerative MedicineCombinatorial peptide libraries: mining for cell-binding peptides.Role of epigenetics in pulmonary hypertensionTarget-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice.Peptides as targeting elements and tissue penetration devices for nanoparticles.Anticipated classes of new medications and molecular targets for pulmonary arterial hypertensionInhalation therapy to treat pulmonary arterial hypertension.Endothelial nanomedicine for the treatment of pulmonary disease.Lipid-based carriers for controlled delivery of nitric oxide.Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs.II. Capsular vaso-mimicry formed by transgenic mammary tumor spheroids implanted ectopically into mouse dorsal skin fold: implications for cellular mechanisms of metastasis.Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension.A novel vascular homing peptide strategy to selectively enhance pulmonary drug efficacy in pulmonary arterial hypertension.Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats.Targeted Antiscarring Therapy for Tissue Injuries.Recombinant Decorin Fusion Protein Attenuates Murine Abdominal Aortic Aneurysm Formation and Rupture.The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series).Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.Antenatal hypoxia and pulmonary vascular function and remodeling.
P2860
Q26772197-08C65D49-D2CE-490D-B550-8BC7B41ADB1FQ26782082-EDA748E4-4AB8-417D-A88D-C4C98C3316F3Q31144876-110FDC2C-EB79-4EE0-A02D-B5086436CBB3Q33764713-891D17F2-1607-46C2-8B9B-1646E67EAEE3Q34411532-CEABB75A-7AC8-401F-B880-0A7710FFE300Q37627407-61186000-FB39-4FD1-8D5A-F386245C5C51Q38105550-C8D4F816-DC1A-42EE-BABA-D91E8EC5335EQ38162947-F9A5797E-BD74-4086-BD7F-7CD8E3C56F17Q38267984-3615590E-68B4-4200-85F1-E5C53671E326Q39100762-028FD30D-8CA5-41E1-BD4E-EBC2D375C8EEQ40854694-6B66A28E-3E84-4273-96FA-06688C30F1CEQ41825036-B7D2758E-6305-42F9-9A30-10B245E4BBF6Q41860260-C0DFA673-D84B-49C7-ADCB-C42BFD5F0003Q41882126-0C524C00-3FFA-45E2-A987-1102A2AE36CEQ41890311-9CC058BE-8BC3-4FF1-9EAE-75C7B19755E2Q42132055-411E6C71-15A6-41B2-94E7-377DD95FA30CQ42275475-6027AE16-9DE4-49F6-A757-3DBFF4E23215Q43198563-BC523D1E-1F97-4251-9E08-C75533B5CD75Q44827142-D5653197-1568-4BCC-AC0C-C6B0F702817BQ47675852-7AE12842-9D33-43F2-80B9-24AF8B3C353CQ48273119-2EC52C4B-8D82-4311-A0A2-6643E4708BA7Q51741338-571B6A9E-E0F4-42A5-BE1B-57C8CBAFA80BQ55110701-106BE14D-DDB2-4322-83F2-DC2DCA8C1ED8
P2860
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@ast
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@en
type
label
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@ast
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@en
prefLabel
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@ast
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@en
P2093
P2860
P1476
Peptide-directed highly selective targeting of pulmonary arterial hypertension.
@en
P2093
David Mann
Ivan McMurtry
Junko Sawada
Masahiko Oka
Masanobu Komatsu
Michie Toba
Takeo Urakami
Tero A H Järvinen
P2860
P304
P356
10.1016/J.AJPATH.2011.02.032
P407
P577
2011-05-06T00:00:00Z